These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 2053141)
1. Donor-specific and random transfusions in HLA-haploidentical kidney transplantation. Garcia LF; Arango AM; Rezonzew R; Correa M; Angel B; Guzman B; Paris SC; Arbelaez M; Henao JE; Mejia G Transplant Proc; 1991 Apr; 23(2):1744-6. PubMed ID: 2053141 [No Abstract] [Full Text] [Related]
2. Donor-specific blood transfusions in HLA-D-disparate one-haplotype-related allografts. Cochrum KC; Hanes D; Potter D; Vincenti F; Amend W; Feduska N; Perkins H; Salvatierra O Transplant Proc; 1979 Dec; 11(4):1903-7. PubMed ID: 161102 [No Abstract] [Full Text] [Related]
3. [Factors influencing the result of kidney transplantation with special reference to the HLA system in conventional immunosuppression]. Wegener S; Auner M; Templin R; Schmitt E; Erdmann T; Fünfhausen G Z Urol Nephrol; 1990 Aug; 83(8):431-8. PubMed ID: 2238884 [TBL] [Abstract][Full Text] [Related]
6. Donor specific transfusions: a five-year experience with alternative protocols. Norman DJ; Henell K; Fletcher L; Barry J Transplant Proc; 1987 Feb; 19(1 Pt 3):2252-4. PubMed ID: 3274504 [No Abstract] [Full Text] [Related]
7. Retrospective study of cyclosporine-prednisolone versus cyclosporine-azathioprine-prednisolone immunosuppression in living donor kidney transplantation. Reissi D; Bardideh A; Samadzadeh B; Razi A Transplant Proc; 1995 Oct; 27(5):2685-6. PubMed ID: 7482875 [No Abstract] [Full Text] [Related]
8. Efficacy of cyclosporine in renal transplantation from HLA haploidentical living donors: no benefit of transfusion or additional azathioprine. Albrechtsen D; Flatmark A; Leivestad T; Brynger H; Frødin L; Groth CG; Lundgren G; Persson N Transplant Proc; 1990 Feb; 22(1):214-5. PubMed ID: 2408207 [No Abstract] [Full Text] [Related]
9. Donor nonspecific blood transfusions before renal transplantation from haplo-mismatched living related donors. Shapira Z; Zamir R; Livni E; Yussim A; Shmueli D; Yehoshua H Transplant Proc; 1989 Feb; 21(1 Pt 2):1834-5. PubMed ID: 2652596 [No Abstract] [Full Text] [Related]
10. High rate of success in kidney cadaveric retransplantation with optimal matching and potent immunosuppression. Hiesse C; Neyrat N; Busson M; Bensadoun H; Lantz O; Bellamy J; Benoit G; Charpentier B; Fries D Transplant Proc; 1990 Aug; 22(4):1909-10. PubMed ID: 2389483 [No Abstract] [Full Text] [Related]
11. Renal transplants from HLA-haploidentical living-related donors. The influence of donor-specific transfusions and different immunosuppressive regimens. Leivestad T; Albrechtsen D; Flatmark A; Thorsby E Transplantation; 1986 Jul; 42(1):35-8. PubMed ID: 3523880 [TBL] [Abstract][Full Text] [Related]
12. Early rejection following donor-specific transfusion prior to HLA-mismatched living related renal transplantation. Sells RA; Scott MH; Prieto M; Bone JM; Evans GM; Millar R; Hills AN Transplant Proc; 1989 Feb; 21(1 Pt 1):1173-4. PubMed ID: 2650088 [No Abstract] [Full Text] [Related]
13. Transplant survival and clinical course after pretransplant HLA-A and B matched blood transfusions: a single centre study. Nubé MJ; Persijn GG; Kalff MW; van Es A; de Graeff J; von Rood JJ Proc Eur Dial Transplant Assoc; 1983; 19():445-52. PubMed ID: 6348745 [TBL] [Abstract][Full Text] [Related]